Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

216,181-216,210 of 319,975

filter-aware
16
The slide uses a timeline to map specific digital product categories to clinical development stages.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
17
The slide uses a process-oriented layout to describe the regulatory and commercialization pathway.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
18
The slide outlines the strategic rationale for a specific clinical trial phase.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
19
The slide outlines a clinical trial design (MMED007) using a timeline-based visualization.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
20
MindMed | Investor Presentation Deck | 32 slidesMindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
21
The slide uses a biological process diagram to explain the drug's mechanism of action (MOA).MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
22
The slide uses a bar chart to bridge the gap between the problem (no drugs) and the solution (R(-)-MDMA alignment with patient needs).MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
23
The slide uses a bar chart to demonstrate the therapeutic index advantage of the R-enantiomer.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
24
The chart shows improvement in social anxiety at 1 month and 6 months, indicating durability of effect.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
25
MindMed | Investor Presentation Deck | 32 slidesMindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
26
The slide highlights three pillars of collaboration: discovery engine, drug delivery, and clinical testing.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
27
The slide highlights a strategic partnership and the resulting research pipeline.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
28
The slide uses a grid layout to associate each executive with a set of logos representing their past experience.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · Team1 hit
29
The slide highlights the depth of experience by listing previous company affiliations for each leader.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · Team1 hit
30
The slide uses a logo-grid approach to establish credibility through past professional experience.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · Team1 hit
31
The slide uses a bulleted list format to highlight core business strengths and specific drug development programs (MM-120 and MM-402).MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
32
This appears to be a section divider or closing slide.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
01
Slide 1
Nemaura Medical | Investor Presentation Deck | 22 slidesNemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations 1 hit
02
Nemaura Medical | Investor Presentation Deck | 22 slidesNemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations 1 hit
03
The slide uses a generic pie chart graphic as a visual metaphor for market segmentation.Nemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations Beat · ProblemLoop · Logic Chain1 hit
04
Uses authority citation (Forbes) to establish the scale of the problem.Nemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations Beat · ProblemLoop · Logic Chain1 hit
05
The slide uses a product photo to demonstrate the scale and form factor of the device.Nemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations Beat · ProductLoop · Logic Chain1 hit
06
Nemaura Medical | Investor Presentation Deck | 22 slidesNemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations Beat · ProductLoop · Logic Chain1 hit
07
The slide uses a 'Target vs Status' framework to demonstrate progress.Nemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations Beat · ProductLoop · Logic Chain1 hit
08
The slide outlines specific milestones including FDA approval, manufacturing scale-up, US market entry, and D2C expansion.Nemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations Beat · ProductLoop · Logic Chain1 hit
09
The slide presents two line charts: one comparing BGM vs Invasive CGM, and one showing raw sugarBEAT data.Nemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations Beat · ProductLoop · Logic Chain1 hit
10
The slide highlights the UI/UX of the companion app for the sugarBEAT CGM device.Nemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations 1 hit
11
The slide uses a pie chart graphic as a visual metaphor for market segmentation, though it does not contain actual data.Nemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations 1 hit
12
Nemaura Medical | Investor Presentation Deck | 22 slidesNemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations 1 hit
13
Nemaura Medical | Investor Presentation Deck | 22 slidesNemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations 1 hit